Business Context and Reporting Period
This Form 8-K is filed by Leisure Acquisition Corp. (not Ensysce Biosciences, Inc., which is the target of a proposed business combination) on February 4, 2021. The report discloses the availability of a replay recording and transcript of an investor conference call held on February 3, 2021, regarding the proposed merger between Leisure and Ensysce Biosciences, Inc.
Financial Metrics
The filing text does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity for either Leisure Acquisition Corp. or Ensysce Biosciences, Inc. This document serves solely as a disclosure of communication materials related to the transaction.
Material Changes
No material financial changes are reported in this filing. The primary event is the release of the investor call transcript (Exhibit 99.1) to provide additional context on the previously announced proposed business combination.
Guidance, Outlook, and Risks
- Transaction Status: The companies are proceeding with a proposed business combination. Leisure intends to file a registration statement on Form S-4, which will include a proxy statement/prospectus.
- Investor Action: Stockholders are urged to read the definitive proxy statement/prospectus when available for important information regarding the transaction.
- Legal Disclaimer: This communication is not a solicitation of proxies or an offer to sell securities. No offer of securities will be made except via a prospectus meeting Securities Act requirements.
- Participants: Directors and executive officers of both Leisure and Ensysce may be deemed participants in the solicitation of proxies.
Key Facts for Investor Verification
- Verify the details of the proposed business combination in the upcoming Form S-4 and definitive proxy statement/prospectus.
- Review the attached transcript (Exhibit 99.1) for management commentary on the transaction rationale and outlook.
- Confirm the voting procedures and timeline for the special meeting of stockholders once the proxy materials are mailed.
- Note that the registrant is Leisure Acquisition Corp. (Ticker: LACQ), not Ensysce Biosciences, Inc.